Read the pH: below 7.35 is acidosis, above 7.45 alkalosis.
Find the value that explains it: PaCO₂ moving opposite to the pH is respiratory, HCO₃⁻ moving with the pH is metabolic.
Look at the other value: normal means uncompensated, abnormal in the compensating direction means partial compensation, and a normal pH with both abnormal means full compensation.
In a metabolic acidosis, compare PaCO₂ with Winter’s formula, 1.5·HCO₃⁻ + 8 ± 2, and calculate the anion gap Na⁺ − (Cl⁻ + HCO₃⁻).
Check a high anion gap with the delta ratio and, when albumin is low, with the corrected gap.
Clinical pharmacokinetics
Rate constant and half-life
k = ln 2/t½ = 0.693/t½
First-order decay
C = C₀·e−kt = C₀·(1/2)t/t½
Two levels
k = ln(C₁/C₂)/Δt
Volume and clearance
Vd = dose/C₀, CL = k·Vd
Loading dose
LD = Vd·C/(S·F)
Maintenance rate
R = CL·Css/(S·F)
Average steady state
Css,avg = S·F·D/(CL·τ)
Steady state
1 − (1/2)ⁿ after n half-lives; ≈ 97% after 5
Infusion
C = (R/CL)(1 − e−kt)
Interval and dose from peak and trough
τ = ln(Cpeak/Ctrough)/k, D = Vd·(Cpeak − Ctrough)
Cockcroft–Gault
CrCl = (140 − age) × kg/(72 × SCr mg/dL), × 0.85 for women
Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.Lab values & electrolytesMedium
A patient takes high-dose biotin supplements for hair and nails. Why should the nurse report this before blood tests?
ABiotin makes the blood clot in the tube before testing
BBiotin causes a true rise in blood glucose in all patients
CBiotin can distort some immunoassays, such as troponin or TSH
DBiotin lowers the hemoglobin by destroying the red cells
2.Lab values & electrolytesHard
A patient has a hemoglobin of 11.2 g/dL (112 g/L), an MCV of 64 fL, a normal ferritin and a normal-to-high red cell count. What is the most likely cause?
AAcute blood loss
BIron deficiency
CThalassemia trait
DVitamin B12 deficiency
3.Arterial blood gas interpretationMedium
A practice gas shows PaCO₂ 23 mmHg (3.1 kPa). Use the rule that in chronic respiratory alkalosis HCO₃⁻ falls by 5 mmol/L for every 10 mmHg that PaCO₂ is below 40, starting from HCO₃⁻ 24 mmol/L, to find the expected HCO₃⁻.
Practice values: Na⁺ 143, Cl⁻ 95 and HCO₃⁻ 17 mmol/L. Calculate the delta ratio (AG − 12)/(24 − HCO₃⁻), using AG = Na⁺ − (Cl⁻ + HCO₃⁻). Give two decimals.
Na⁺ 143 mmol/LCl⁻ 95 mmol/LHCO₃⁻ 17 mmol/L
delta ratio =
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). A patient receives an IV bolus of 220 mg of gentamicin. The level back-extrapolated to time zero is 12 mg/L and the half-life is 2 h. Find the clearance CL in L/h.
D = 220 mgC₀ = 12 mg/Lt½ = 2 h
CL = L/h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A 75 kg patient on regular tobramycin doses is at steady state. The target is a peak of 8 mg/L and a trough of 1 mg/L, and the volume of distribution is 0.25 L/kg. Assuming rapid IV doses, what dose D raises the level from the trough to the peak?
75 kgVd = 0.25 L/kgCpeak = 8 mg/LCtrough = 1 mg/L
D = mg
7.Clinical nursingMedium
Which pattern is typical of relapsing–remitting multiple sclerosis?
AA single stroke that leaves permanent weakness
BConstant weakness that starts in the feet and spreads upwards after a viral illness
CAttacks of symptoms, such as visual loss or numbness, that improve between relapses
DSudden severe headache with neck stiffness
8.Clinical nursingHard
Why are liquid medicines for nasogastric tubes drawn up in dedicated enteral (oral) syringes rather than IV syringes?
AEnteral syringes measure doses less accurately
BTo prevent accidental intravenous administration
CEnteral syringes keep the medicine sterile
DIV syringes cannot hold liquid medicines
3Solutions
1.Lab values & electrolytes
Answer: C · Biotin can distort some immunoassays, such as troponin or TSH
Why this is the answer
Many immunoassays use biotin-streptavidin binding, and high blood biotin levels can give falsely high or low results, for example a falsely low troponin or abnormal thyroid tests. The laboratory and prescriber should know about biotin use.Checked against:Troponin Test · MedlinePlus (NIH) (2023); Biotin Interference with Troponin Lab Tests - Assays Subject to Biotin Interference · U.S. FDA (2022)
Answer
C · Biotin can distort some immunoassays, such as troponin or TSH
2.Lab values & electrolytes
Answer: C · Thalassemia trait
Why this is the answer
Thalassemia trait causes microcytosis from reduced globin production, often with a normal or high red cell count and normal ferritin. Iron deficiency has low ferritin. Iron supplements do not help thalassemia trait and can cause iron overload.Checked against:Thalassemia - Medical Encyclopedia · MedlinePlus (NIH) (2026); Red Blood Cell (RBC) Indices · MedlinePlus (NIH) (2024)
Answer
C · Thalassemia trait
3.Arterial blood gas interpretation
Answer: HCO₃⁻ = 15.5 mmol/L
Expected compensation: in metabolic acidosis Winter’s formula predicts PaCO₂ = 1.5·HCO₃⁻ + 8 ± 2 mmHg; a measured value above that range points to an additional respiratory acidosis, below it to an additional respiratory alkalosis. The anion gap AG = Na⁺ − (Cl⁻ + HCO₃⁻), normally about 8–12 mmol/L, separates high-gap from normal-gap metabolic acidosis; low albumin hides a high gap (add 2.5 per g/dL that albumin is below 4.0). The delta ratio (AG − 12)/(24 − HCO₃⁻) between about 0.8 and 2 fits a pure high-gap acidosis (some texts use 1 instead of 0.8), below that an added normal-gap acidosis, and above 2 an added metabolic alkalosis.
Change in PaCO₂
|23 − 40| = 17 mmHg → 1.7 × 10 mmHg
Expected HCO₃⁻
HCO₃⁻ = 24 − 5·1.7 = 15.5 mmol/L
Answer
HCO₃⁻ = 15.5 mmol/L
4.Arterial blood gas interpretation
Answer: delta ratio = 2.714
Expected compensation: in metabolic acidosis Winter’s formula predicts PaCO₂ = 1.5·HCO₃⁻ + 8 ± 2 mmHg; a measured value above that range points to an additional respiratory acidosis, below it to an additional respiratory alkalosis. The anion gap AG = Na⁺ − (Cl⁻ + HCO₃⁻), normally about 8–12 mmol/L, separates high-gap from normal-gap metabolic acidosis; low albumin hides a high gap (add 2.5 per g/dL that albumin is below 4.0). The delta ratio (AG − 12)/(24 − HCO₃⁻) between about 0.8 and 2 fits a pure high-gap acidosis (some texts use 1 instead of 0.8), below that an added normal-gap acidosis, and above 2 an added metabolic alkalosis.
Anion gap
AG = 143 − (95 + 17) = 31
Delta ratio
(31 − 12)/(24 − 17) = 19/7 = 2.714
Answer
delta ratio = 2.714
Above 2: an added metabolic alkalosis.
5.Clinical pharmacokinetics
Answer: CL = 6.354 L/h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Volume of distribution
Vd = 220/12 = 18.33 L
Rate constant
k = 0.693/2 = 0.3466 h⁻¹
Clearance
CL = 0.3466·18.33 = 6.354 L/h
Answer
CL = 6.354 L/h
6.Clinical pharmacokinetics
Answer: D = 131.3 mg
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Volume of distribution
Vd = 0.25·75 = 18.75 L
Dose
D = 18.75·(8 − 1) = 131.3 mg
Answer
D = 131.3 mg
In practice the dose is rounded to a convenient amount.
7.Clinical nursing
Answer: C · Attacks of symptoms, such as visual loss or numbness, that improve between relapses
Why this is the answer
MS causes demyelination in the brain and spinal cord. Many patients first have attacks such as optic neuritis or sensory symptoms, with partial or full recovery between relapses.
Answer
C · Attacks of symptoms, such as visual loss or numbness, that improve between relapses
8.Clinical nursing
Answer: B · To prevent accidental intravenous administration
Why this is the answer
Giving an oral or enteral medicine intravenously can be fatal. Enteral syringes with non-IV connectors, such as ENFit, make this wrong-route error much less likely.
Answer
B · To prevent accidental intravenous administration